Advances in cholesterol-lowering drugs within five years

February 3, 2014 by David Ellis

(Medical Xpress)—A leading cardiology expert at the University of Adelaide predicts that a new class of advanced cholesterol-reducing drugs could be ready for patient use within the next five years, helping to prevent heart attack and stroke.

Speaking in the lead up to Heart Research Day (14 February), Professor Stephen Nicholls says the University of Adelaide is leading a major, worldwide clinical study into the new class of drugs, which aim to reduce cholesterol and remove harmful plaque build-ups in the and arteries.

Professor Nicholls is Professor of Cardiology at the University of Adelaide and Consultant Cardiologist at the Royal Adelaide Hospital, and is the Heart Foundation Heart Health Theme Leader for the new South Australian Health & Medical Research Institute.

"Cholesterol is one of the key causes of plaque build-up in the blood vessels, or clogged arteries as they're often known, which can lead to or stroke. These are serious issues and although we've come so far in treating high cholesterol there's still much more that can be done," Professor Nicholls says.

He says controversy caused by the ABC television program Catalyst last year, which described as "toxic", has scared many patients into stopping their medication.

"This controversy has had a massive impact on our ability as clinicians to treat the problem and prevent serious illness and death, so from my point of view it is a concern," he says.

"The fact of the matter is that statins, which are the class of drugs currently widely used around the world, are good at lowering cholesterol and they can help to treat serious health problems. But they don't do the job completely in the way we'd like them to, which is why further studies have been underway for some time to look at alternatives."

The latest clinical trial involves 200 hospitals in 20 countries around the world, including the Royal Adelaide Hospital.

"We're seeing evidence that these drugs will drive cholesterol levels right down, equivalent to where they were when we were newborn babies. This is a significant development, one that would revolutionise our approach to treating people with high , therefore helping to prevent disease and death," Professor Nicholls says.

He says these advanced drugs are at the later stages of clinical trials. "If approved, and we have every reason to believe they will be, we would expect the new drugs to be used by patients within the next five years. That's great news for the future health of our population," he says.

Explore further: ACC/AHA publish new guideline for management of blood cholesterol

Related Stories

ACC/AHA publish new guideline for management of blood cholesterol

November 12, 2013

The American College of Cardiology and the American Heart Association today released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, ...

New therapy to lower sky-high cholesterol

January 30, 2014

University of Rochester Medical Center cardiologists are first in Upstate New York to offer a blood-cleansing therapy for people with extremely high cholesterol, including two-time heart attack survivor Bob Guesno, whose ...

The skinny on fat and cholesterol

November 18, 2013

Last week, the Food and Drug Administration proposed banning transfat—partially hydrogenated oil—from restaurants and grocery shelves because it raises bad cholesterol and lowers good cholesterol, contributing to heart ...

Recommended for you

Nigeria: Clean-burning stoves improve health for new mothers

January 13, 2017

In a small clinical trial that replaced widely used biomass and kerosene cookstoves with clean-burning ethanol stoves, a team of researchers from the University of Chicago and the University of Ibadan (Nigeria) was able to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.